Fenopron™ (Fenoprofen Calcium) 300
Click to enlarge
NSAID

Fenopron™ (Fenoprofen Calcium) 300

300 mg | 100 ct.

NDC:
61825-0311-10

Fenopron™ (fenoprofen calcium) — A nonsteroidal anti-inflammatory, anti-arthritic agent with analgesic and antipyretic effects, indicated for the relief of mild to moderate pain as well as the signs and symptoms of rheumatoid arthritis and osteoarthritis

BG
Warning

Risk of Serious Cardiovascular and Gastrointestinal Events

See full prescribing information for complete boxed warning.

  • Non-Steroidal Anti-Inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use.
  • Fenoprofen is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
  • NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.

INDICATIONS & USAGE

FENOPRON™ is indicated for:

  • Relief of mild to moderate pain in adults
  • Relief of the signs and symptoms of rheumatoid arthritis
  • Relief of the signs and symptoms of osteoarthritis

DOSAGE AND ADMINISTRATION

General Dosing Instructions

Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. FENOPRON™ may be administered with meals or with milk.

Analgesia

For the treatment of mild to moderate pain, the recommended dosage is 200 mg given orally every 4 to 6 hours, as needed.

Rheumatoid Arthritis and Osteoarthritis

For the relief of signs and symptoms of rheumatoid arthritis or osteoarthritis the recommended dose is 400 to 600 mg given orally, 3 or 4 times a day. The dose should be tailored to the needs of the patient and may be increased or decreased depending on the severity of the symptoms. Total daily dosage should not exceed 3,200 mg.

CONTRAINDICATIONS

  • Known hypersensitivity to fenoprofen or any components of the drug product
  • History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs
  • In the setting of CABG surgery

WARNINGS AND PRECAUTIONS

  • Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests persist or worsen or if clinical signs and symptoms of liver disease develop
  • Hypertension: Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs. Monitor blood pressure
  • Heart Failure and Edema: Avoid use of fenoprofen calcium in patients with severe heart failure unless benefits are expected to outweigh risk of worsening heart failure
  • Renal Toxicity: Monitor renal function in patients with renal or hepatic impairment, heart failure, dehydration, or hypovolemia. Avoid use of fenoprofen calcium in patients with advanced renal disease unless benefits are expected to outweigh risk of worsening renal function
  • Anaphylactic Reactions: Seek emergency help if an anaphylactic reaction occurs
  • Exacerbation of Asthma Related to Aspirin Sensitivity: Fenoprofen calcium is contraindicated in patients with aspirin-sensitive asthma. Monitor patients with preexisting asthma (without aspirin sensitivity)
  • Serious Skin Reactions: Discontinue fenoprofen calcium at first appearance of skin rash or other signs of hypersensitivity
  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Discontinue and evaluate clinically
  • Fetal Toxicity: Limit use of NSAIDs, including fenoprofen calcium, between about 20 to 30 weeks in pregnancy due to the risk of oligohydramnios/fetal renal dysfunction. Avoid use of NSAIDs in women at about 30 weeks gestation and later in pregnancy due to the risks of oligohydramnios/fetal renal dysfunction and premature closure of the fetal ductus arteriosus
  • Hematologic Toxicity: Monitor hemoglobin or hematocrit in patients with any signs or symptoms of anemia

ADVERSE REACTIONS

The following adverse reactions are discussed in greater detail in other sections of the labeling:

  • Cardiovascular Thrombotic Events
  • GI Bleeding, Ulceration and Perforation
  • Hepatotoxicity
  • Hypertension
  • Heart Failure and Edema
  • Renal Toxicity and Hyperkalemia
  • Anaphylactic Reactions
  • Serious Skin Reactions
  • Hematologic Toxicity

To report SUSPECTED ADVERSE REACTIONS, contact Galt Pharmaceuticals, LLC or FDA at 1-800-FDA-1088 or WWW.FDA.GOV/MEDWATCH.

HOW SUPPLIED / STORAGE AND HANDLING

The 300 mg capsule is a hard gelatin capsule with an orange opaque cap and a yellow opaque body, imprinted with “R” on the cap and “8” on the body in black ink.

  • NDC 61825-311-10 — Bottles of 100

Store at room temperature 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Preserve in well-closed containers.

Full Prescribing Information: DailyMed

⬇ Download PDF
⬇ Download PDF
⬇ Download
⬇ Download
pdflegacy